Literature DB >> 10724523

Ultrastructure abnormalities in proteoglycans, collagen fibrils, and elastic fibers in normal and myxomatous mitral valve chordae tendineae.

S Akhtar1, K M Meek, V James.   

Abstract

Normal and myxomatous chordae tendineae were studied using light and electron microscopy, to assess the alterations in the appearance and mutual arrangement of proteoglycans, collagen fibrils, and elastic fibers. Specific staining with ruthenium red and cuprolinic blue in a critical electrolyte concentration mode were used to localize proteoglycans. Fresh tissues were fixed in glutaraldehyde containing the cationic dyes and embedded into Spurr resin. Semithin sections of LR White (London Resin Co., Basingstoke, U.K.)-embedded tissue were used for histochemistry. In normal chordae tendineae, the fibrosa comprised close-packed collagen fibrils intermixed with elastic fibers. These were surrounded by a thin layer of elastic fibers and collagen fibrils, both of which were closely associated with proteoglycans. In myxomatous chordae tendineae, alterations were observed in the connective tissue. Proteoglycans were more abundant and were distributed throughout the tissue. The outermost layer was transformed into an undifferentiated electron-dense mass surrounding the central fibrosa, which contained degraded elastic fibers and collagen fibrils. Collagen fibrils had faint banding or lacked a banding pattern altogether. Spaces between collagen fibrils were occupied by abnormal proteoglycans or proteoglycan aggregates. Elastic fibers showed varying degrees of degeneration and were occasionally replaced by electron-lucent spaces containing microfibrils. Accumulation of abnormal proteoglycan was also observed around degenerated elastic fibres and collagen fibrils.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10724523     DOI: 10.1016/s1054-8807(99)00004-6

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  17 in total

Review 1.  Mitral valve disease--morphology and mechanisms.

Authors:  Robert A Levine; Albert A Hagége; Daniel P Judge; Muralidhar Padala; Jacob P Dal-Bianco; Elena Aikawa; Jonathan Beaudoin; Joyce Bischoff; Nabila Bouatia-Naji; Patrick Bruneval; Jonathan T Butcher; Alain Carpentier; Miguel Chaput; Adrian H Chester; Catherine Clusel; Francesca N Delling; Harry C Dietz; Christian Dina; Ronen Durst; Leticia Fernandez-Friera; Mark D Handschumacher; Morten O Jensen; Xavier P Jeunemaitre; Hervé Le Marec; Thierry Le Tourneau; Roger R Markwald; Jean Mérot; Emmanuel Messas; David P Milan; Tui Neri; Russell A Norris; David Peal; Maelle Perrocheau; Vincent Probst; Michael Pucéat; Nadia Rosenthal; Jorge Solis; Jean-Jacques Schott; Ehud Schwammenthal; Susan A Slaugenhaupt; Jae-Kwan Song; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2015-10-20       Impact factor: 32.419

2.  Tbx20 regulation of endocardial cushion cell proliferation and extracellular matrix gene expression.

Authors:  Elaine L Shelton; Katherine E Yutzey
Journal:  Dev Biol       Date:  2006-10-03       Impact factor: 3.582

3.  Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease.

Authors:  Rajeev Mahimkar; Anita Nguyen; Michael Mann; Che-Chung Yeh; Bo-Qing Zhu; Joel S Karliner; David H Lovett
Journal:  Cardiovasc Pathol       Date:  2008-10-01       Impact factor: 2.185

4.  Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease.

Authors:  Loren E Dupuis; Daniel R McCulloch; Jessica D McGarity; Alexandria Bahan; Andy Wessels; Deidra Weber; A Megan Diminich; Courtney M Nelson; Suneel S Apte; Christine B Kern
Journal:  Dev Biol       Date:  2011-07-01       Impact factor: 3.582

Review 5.  Differentiating the aging of the mitral valve from human and canine myxomatous degeneration.

Authors:  Patrick S Connell; Richard I Han; K Jane Grande-Allen
Journal:  J Vet Cardiol       Date:  2012-02-24       Impact factor: 1.701

6.  Tgfβ-Smad and MAPK signaling mediate scleraxis and proteoglycan expression in heart valves.

Authors:  Damien N Barnette; Alexia Hulin; A S Ishtiaq Ahmed; Alain C Colige; Mohamad Azhar; Joy Lincoln
Journal:  J Mol Cell Cardiol       Date:  2013-10-21       Impact factor: 5.000

7.  Pressure applied during surgery alters the biomechanical properties of human saphenous vein graft.

Authors:  Necla Ozturk; Nehir Sucu; Ulku Comelekoglu; Banu Coskun Yilmaz; Barlas Naim Aytacoglu; Ozden Vezir
Journal:  Heart Vessels       Date:  2012-03-29       Impact factor: 2.037

8.  Fibronectin-based isolation of valve interstitial cell subpopulations: relevance to valve disease.

Authors:  Elizabeth H Stephens; Thanh N Huynh; Jennifer D Cieluch; K Jane Grande-Allen
Journal:  J Biomed Mater Res A       Date:  2010-01       Impact factor: 4.396

9.  Abundance and location of proteoglycans and hyaluronan within normal and myxomatous mitral valves.

Authors:  Vishal Gupta; Janet E Barzilla; Joe S Mendez; Elizabeth H Stephens; Elaine L Lee; C David Collard; Rodolfo Laucirica; Paul H Weigel; Kathryn J Grande-Allen
Journal:  Cardiovasc Pathol       Date:  2008-07-14       Impact factor: 2.185

Review 10.  Current Discoveries and Interventions for Barlow's Disease.

Authors:  Juan A Siordia
Journal:  Curr Cardiol Rep       Date:  2016-08       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.